Alphabet's health efforts: mammography and pathology AI research, Med-PaLM/MedGemma medical models, DeepMind's AlphaFold, and Isomorphic Labs drug design.
Google, through Google Health, DeepMind and Verily, based in Mountain View and listed as GOOGL, runs Alphabet's health efforts: mammography and pathology AI research, the Med-PaLM and MedGemma medical models, DeepMind's AlphaFold and drug design through Isomorphic Labs. Its landmark AI papers covered breast screening and lymph node metastasis detection, AlphaFold 3 came from DeepMind, and Isomorphic holds partnerships with Lilly and Novartis. OnCo links it to AI compute and model platforms, AI in radiology, AI-driven drug discovery and structural biology infrastructure. Whether its research results turn into deployed clinical tools, which has proved harder than publishing them, is the open question. Isomorphic Labs has its own page.
Shares AI compute and model platforms for oncology and the tag supporting.
Shares AI compute and model platforms for oncology, AI in radiology and the tag supporting.
Shares Structural biology infrastructure (cryo-EM, synchrotrons, AlphaFold) and the tag supporting.
Shares AI-driven drug & target discovery and the tag supporting.
Shares AI compute and model platforms for oncology and the tag supporting.
Shares Structural biology infrastructure (cryo-EM, synchrotrons, AlphaFold), AI-driven drug & target discovery.
Open-source projects that this organisation maintains, from OnCo's own catalogue: licence and last activity as the repository reported them on the day of the fetch. Listing is not endorsement; check the licence before reuse and the validation before clinical use.
Google's deep-learning somatic variant caller, an extension of DeepVariant for tumour-normal and tumour-only sequencing.